08-06-2022 | Tocilizumab | Letter to Editor
Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
Published in: Journal of Clinical Immunology | Issue 6/2022
Login to get access08-06-2022 | Tocilizumab | Letter to Editor
Published in: Journal of Clinical Immunology | Issue 6/2022
Login to get access